Why Big Pharma Allows the Gray Market (You're the Lab Rats)

Why Big Pharma Lets the Gray Market Exist

That companies like Eli Lilly are completely okay with the gray market is not an accident, and once you look at what they get out of it, the whole thing makes sense. The gray market runs their market research for free.

Start with the full chain so you can see where you sit in it.

A pharmaceutical company develops a compound, runs it through trials, and then has to answer a much harder question than "does it work," which is "will people actually take it, stay on it, and talk about it." Trials tell you about efficacy and safety in a controlled group. They tell you almost nothing about whether a drug becomes a cultural phenomenon or dies quietly on pharmacy shelves.

That second question normally costs a fortune to answer, and you only get the answer after launch, when the money is already spent.

Unless somebody else answers it for you first.

And the idea that the gray market exists by utilizing this research loophole that a lot of these companies are abusing is something that they leave open from an FDA standpoint as well as a federal government standpoint, because this allows them to use those gray market companies as a way to turn you guys into lab rats.

The loophole itself works like this, since a compound sold "for research use only, not for human consumption" sits outside the rules that govern drugs sold for people, so the seller is technically selling a chemical to a laboratory, and what the buyer does with it afterward is the buyer's problem, which everybody involved understands is a fiction built entirely so the label can serve as the legal defense.

None of this is hard to enforce. It happens constantly in other categories, and it happens fast when a regulator decides something is a priority. So when it does not happen, that tells you something about priority.

I remember when Reda first came out and people started talking about it, it was probably three or four years ago.

And if you remember when it first started coming out and people were talking about it and selling it, there was no pushback.

No letters, no takedowns, no quiet pressure on the platforms. You could make content talking about Reda True Tide and it was like viral, and millions of users were on it, and the companies who owned the molecule said nothing at all while their intellectual property was being sold by people who had never run a trial in their lives, and that silence, more than anything else, was the whole strategy.

Think about what they were watching during those years. Dosing patterns in people who titrate themselves rather than following a prescribing guideline. Side effect chatter in forums, where people report things they would never tell a doctor, along with which populations self-selected into using it in the first place. How long people stayed on before they quit, why they quit, and what the market would bear on price once real money was on the line.

That is a longitudinal observational dataset on a scale no sponsor could afford to run, generated by people who volunteered, paid for their own compound, and reported their own outcomes in public.

Now, we're years into the gray market being hyper mature, with billions of dollars of sales of Reda True Tide, and effectively what they did is they used you guys as a test group and they validated the product in the market.

Only once that validation is locked in does the pushback actually show up. Once the demand curve is proven and the branded product is ready to capture it, the legal letters start, the compounding gets restricted, the shortage list gets updated, and the same molecule that was freely discussed for years becomes something you can only access through the channel they own.